A curvature-sensing peptide is used to disrupt exosomes for enhanced cancer immunotherapy.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Han, Y., Liu, D. & Li, L. Am. J. Cancer Res. 10, 727–742 (2020).
Tumeh, P. C. et al. Nature 515, 568–571 (2014).
Yi, M. et al. Mol. Cancer 17, 1–14 (2018).
Chen, G. et al. Nature 560, 382–386 (2018).
Poggio, M. et al. Cell 177, 414–427.e413 (2019).
Zhang, H., Lu, J., Liu, J., Zhang, G. & Lu, A. J. Enzyme Inhib. Med. Chem. 35, 1322–1330 (2020).
Ostrowski, M. et al. Nat. Cell Biol. 12, 19–30 (2010).
Jackman, J. A. et al. Nat. Mater. 17, 971–977 (2018).
Shin, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-023-01515-2 (2023).
Papadaki, M. A. et al. Cancers 12, 376 (2020).
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Gong, N., Hamilton, A.G. & Mitchell, M.J. Exosome-disrupting peptides for cancer immunotherapy. Nat. Mater. 22, 530–531 (2023). https://doi.org/10.1038/s41563-023-01525-0